Rhodiola vs Ashwagandha: Which Is Better for Stress and Sleep?

The Short Answer
Both herbs are sold for stress, but they aren’t equals.
- Ashwagandha has more research and somewhat stronger results, especially for stress and sleep. A 2026 review counted 19 trials of ashwagandha against 5 of rhodiola (Łuszczak and Kocki 2026). The US government’s center for complementary health research (NCCIH) says some ashwagandha products may help with stress and insomnia.
- Rhodiola’s research is thin and mixed. NCCIH says there isn’t enough reliable evidence to say it helps with anything (NCCIH), and its fatigue trials contradict each other.
- Their risks are different. Ashwagandha has been linked to rare liver injury and isn’t recommended for people with thyroid or autoimmune conditions. Rhodiola’s main concern is how it mixes with antidepressants and some blood-thinning and anti-seizure drugs.
- Taking both together hasn’t been studied. We found no trial that tested the combination.
If your main goal is…
- Stress or anxiety: the evidence leans toward ashwagandha, though it’s still rated low quality. Rhodiola has one small positive trial for stress-related burnout.
- Better sleep: ashwagandha has a small but real effect across several trials. Rhodiola has almost no sleep research, and trouble sleeping is one of its side effects.
- More energy or less tiredness: neither has good evidence. Rhodiola’s trials point both ways; ashwagandha’s one fatigue trial found no difference from a dummy pill.
- Low mood or depression: neither is a treatment for depression. See a doctor.
Whichever you’re considering, read the safety section first, especially if you take any prescription medicine.
Table of Contents
At a Glance
| Ashwagandha | Rhodiola | |
|---|---|---|
| What it is | Root (sometimes leaf) of an evergreen shrub, Withania somnifera (NCCIH) | Root of a cold-climate mountain and Arctic plant, Rhodiola rosea (NCCIH) |
| Traditional use | Ayurveda, India’s traditional medicine (NCCIH) | Russia, Scandinavia and Europe, for fatigue, endurance, low mood and altitude sickness (NCCIH) |
| Most studied for | Stress, anxiety, sleep (ODS) | Tiredness, mild depression (Drugs.com) |
| Strength of evidence | Some support, but rated low quality (Akhgarjand 2022) | Contradictory (Ishaque 2012) |
| Amounts used in trials | 240–600 mg a day (Lopresti 2019; Salve 2019) | 340–1,360 mg a day (Olsson 2009; Mao 2015) |
| Common side effects | Drowsiness, upset stomach, diarrhea, vomiting (NCCIH) | Dizziness, headache, trouble sleeping, dry mouth (NCCIH) |
| Biggest safety concern | Rare liver injury; thyroid and autoimmune conditions (NCCIH) | Antidepressants, warfarin, phenytoin (MSKCC) |
| Pregnancy | Avoid (NCCIH) | Not recommended; safety unknown (EMA) |
| Legal status | Banned from sale in Denmark (Fødevarestyrelsen) | Accepted in the EU as a traditional remedy (EMA) |
| Sustainability | Not flagged as a concern | Mostly wild-harvested; international trade regulated (CITES) |
Is One Calming and the Other Energizing?
That’s how they’re usually sold: ashwagandha to wind down, rhodiola to perk up. There’s something to it, but it comes from tradition and side effects rather than from trials comparing the two.
Ashwagandha can cause drowsiness (NCCIH), and lab studies suggest it has sedating effects (MSKCC). Rhodiola was traditionally used to boost mental and physical performance (MSKCC), and trouble sleeping is one of its side effects.
The picture is messier than the marketing, though. Older studies suggest rhodiola may be stimulating at low doses but sedating at high ones (Drugs.com). And in one fatigue trial, described below, people on the “energizing” herb ended up more tired than people on a dummy pill.
What the Research Shows
Stress
Ashwagandha. In one trial, 60 stressed adults took 240 mg a day of ashwagandha extract or a dummy pill for 60 days. Anxiety dropped more on ashwagandha, and so did morning levels of cortisol, the main stress hormone (Lopresti et al. 2019). The lead researcher disclosed past funding from an extract maker for unrelated studies. In another trial of 60 stressed adults, both 250 mg and 600 mg a day lowered stress scores and cortisol over eight weeks (Salve et al. 2019).
When researchers pooled 12 trials covering about 1,000 people, ashwagandha lowered stress and anxiety scores on average. But results varied a lot between studies, and the reviewers rated their confidence in the finding as low (Akhgarjand et al. 2022).
Rhodiola. The main stress trial gave 60 adults with stress-related exhaustion 576 mg a day or a dummy pill for four weeks. Both groups improved, partly a placebo effect, but the rhodiola group did somewhat better on a burnout questionnaire and some attention tests (Olsson et al. 2009). One author, Alexander Panossian, was later thanked in another trial as working for the Swedish Herbal Institute, the company that supplied that trial’s extract; that trial says the company had no role in running or reporting it (Mao et al. 2015).
European regulators allow rhodiola to be sold for stress-related tiredness, but based on its long history of use, not on trial results (EMA).
More options: herbs for stress-related fatigue.
Sleep
Ashwagandha has the stronger case. A 2021 analysis of five studies, covering 372 adults who took 250–600 mg a day for 6–12 weeks, found a small but real improvement in sleep compared with a dummy pill. The effect was bigger at 600 mg, after at least eight weeks, and in people with insomnia (ODS).
Rhodiola has very little sleep research. Drugs.com mentions improved sleep, but the studies behind that were mostly about tiredness, not sleep (Drugs.com).
Tiredness and energy
Rhodiola’s results point both ways. A review of 11 trials found a benefit in about half, but all the trials had design flaws (Ishaque et al. 2012). In a later trial, 48 nursing students working shifts took rhodiola or a dummy pill for six weeks, and the dummy-pill group ended up less tired. The authors said rhodiola made fatigue worse, while warning that one small trial should be read with caution (Punja et al. 2014).
Ashwagandha hasn’t done better. In a trial of overweight men aged 40 to 70 with mild fatigue, energy improved over eight weeks in both groups, with no real difference between ashwagandha and the dummy pill (Lopresti et al. 2019).
Mood and depression
Rhodiola is often called a natural antidepressant. The best trial doesn’t back that up. Fifty-seven people with mild to moderate depression took rhodiola, the antidepressant sertraline (Zoloft) or a dummy pill for 12 weeks. All three groups improved a little, and the differences between them were too small to count (Mao et al. 2015). Rhodiola did cause fewer side effects than sertraline (30% of people against 63%).
An earlier, smaller trial of the same extract did find a benefit over a dummy pill (Drugs.com). Expert guidelines are split. A 2022 international taskforce doesn’t recommend rhodiola for depression (Sarris et al. 2022), while Canada’s 2023 guidelines list it as a third-line option for mild depression only (Lam et al. 2024).
For ashwagandha, NCCIH calls the evidence on anxiety unclear (NCCIH).
Neither herb replaces proper care for depression or anxiety. If you’re struggling, talk to a doctor.
Exercise
Both are mixed. For rhodiola, a few early studies suggested better endurance, but most recent trials found no effect (MSKCC; Drugs.com). For ashwagandha, NCCIH says there isn’t enough evidence (NCCIH), though MSKCC cites limited data suggesting a benefit (MSKCC).
Safety: How the Risks Differ
This is where the two herbs differ most.
| Who should be careful | Ashwagandha | Rhodiola |
|---|---|---|
| People with liver disease | Avoid (LiverTox) | No liver-injury entry in LiverTox, but not well studied (LiverTox) |
| People with thyroid or autoimmune conditions | Not recommended (NCCIH) | No warning found |
| People having surgery soon | Not recommended (NCCIH) | General caution only (Drugs.com) |
| People on antidepressants | Not flagged by NCCIH | Use with caution (MSKCC) |
| People on warfarin or seizure drugs | Seizure drugs flagged (NCCIH) | Both flagged, based on one small study (MSKCC; Thu 2016) |
| People on blood pressure medicine | Flagged (NCCIH) | Losartan flagged (NCCIH) |
| Pregnant or breastfeeding | Avoid (NCCIH) | Not recommended (EMA) |
| Men with hormone-sensitive prostate cancer | Avoid (NCCIH) | No warning found |
| How long safety has been studied | Up to about 3 months (NCCIH) | Up to 12 weeks (NCCIH) |
Ashwagandha’s main risks
Liver. The NIH’s database of drugs and supplements that harm the liver (LiverTox) rates ashwagandha as a likely cause of liver injury. Cases are rare and usually show up 2 to 12 weeks after starting, often with yellowing skin or eyes (jaundice) and itching. A few severe cases, including deaths and emergency liver transplants, happened mostly in people who already had liver disease, and LiverTox says people with cirrhosis or advanced liver disease should avoid it (LiverTox).
Thyroid, immune system and surgery. NCCIH says ashwagandha isn’t recommended before surgery or for people with thyroid or autoimmune conditions (NCCIH). There are case reports of an overactive thyroid that cleared up once people stopped taking it (MSKCC).
Medicines. NCCIH lists possible interactions with drugs for diabetes, high blood pressure, seizures and thyroid conditions, with sedatives, and with drugs that suppress the immune system (NCCIH). MSKCC adds that people on sleeping pills or anxiety drugs like benzodiazepines should probably avoid it (MSKCC).
Pregnancy. NCCIH says to avoid it in pregnancy and while breastfeeding (NCCIH). MSKCC says high doses may raise the risk of miscarriage (MSKCC), though the American Herbal Pharmacopoeia disputes this (ODS).
Regulators. Denmark has banned the sale of ashwagandha products. Its food authority points to a Danish risk assessment that found negative effects on sex hormones and reproduction, and possible effects on the thyroid, the immune system and the nervous system (Fødevarestyrelsen). France’s food safety agency advises against it for some groups, including pregnant women and people with hormone disorders (ODS). The EU has no approved monograph for ashwagandha because there wasn’t enough evidence to write one (EMA).
Rhodiola’s main risks
Antidepressants. One woman developed a fast, irregular heartbeat after three days of taking rhodiola with her antidepressant, and lab studies suggest rhodiola could add to these drugs’ effects. MSKCC advises caution (MSKCC).
Warfarin and phenytoin. Rhodiola slightly slows a liver enzyme that clears the blood thinner warfarin and the seizure drug phenytoin, which could push their levels up. Both drugs have a small margin between the right dose and too much (MSKCC). This is based on one study in 13 healthy volunteers, which measured the enzyme using a blood pressure drug and didn’t test warfarin or phenytoin directly (Thu et al. 2016). NCCIH also says interactions with the blood pressure drug losartan have been reported (NCCIH). European regulators, by contrast, say no clinically important interactions have been seen (EMA).
Side effects and age. Usually mild: dizziness, dry mouth, headache, trouble sleeping, and less often nausea, stomach pain or rash. European regulators don’t recommend it for anyone under 18 (EMA).
Liver. LiverTox has no entry for rhodiola itself (LiverTox). It shows up as one ingredient in some SLIMQUICK weight-loss products linked to liver injury, but LiverTox says no single ingredient could be blamed (LiverTox).
Can You Take Rhodiola and Ashwagandha Together?
Nobody has tested the combination. A 2026 review of both herbs found no trial that gave them together (Łuszczak and Kocki).
If you take both, you take on both sets of risks, and some of them overlap: blood pressure medicines, drugs that act on the brain and nervous system, and pregnancy.
A pharmacist can check your situation. Bring:
- both product labels (which plant, which part, how much per serving, and any other ingredients)
- a list of every medicine and supplement you take, especially antidepressants, blood thinners, seizure, thyroid, blood pressure, diabetes and immune-suppressing drugs
- any liver, thyroid or autoimmune condition, pregnancy plans, and upcoming surgery
Side by Side: What Each Was Studied For
| Goal | Ashwagandha | Rhodiola |
|---|---|---|
| Stress | Lower stress scores in two trials; overall evidence rated low quality | One small positive trial for burnout; accepted in the EU on traditional use |
| Cortisol (stress hormone) | Lower in two stress trials; no difference in a trial of men aged 40–70 | Different morning cortisol pattern in one trial |
| Sleep | Small but real improvement across five trials | Little research; trouble sleeping is a side effect |
| Tiredness | No difference from a dummy pill in one trial | Mixed; one trial found it made fatigue worse |
| Depression | Not the focus of the trials here | Conflicting; best trial found no difference from a dummy pill |
| Exercise | Not enough evidence | Mixed |
For the full picture on each herb, see our ashwagandha and rhodiola pages. Other options, such as holy basil, are on our adaptogens page, and we explain what “adaptogen” means separately.
Questions People Ask
Can I take ashwagandha and rhodiola together?
It hasn’t been studied, and each herb’s risks still apply. If you want to try it, check with a pharmacist first; see what to bring.
Which is better for lowering cortisol?
Ashwagandha has more evidence. Two trials in stressed adults found it lowered cortisol more than a dummy pill (Lopresti 2019; Salve 2019), though a trial in men aged 40 to 70 found no difference (Lopresti 2019). Rhodiola has one trial showing a changed morning cortisol pattern (Olsson 2009).
What shouldn’t you mix with rhodiola?
Mainly antidepressants, the blood thinner warfarin and the seizure drug phenytoin, and possibly the blood pressure drug losartan. Other blood pressure medicines and stimulants are a theoretical concern (MSKCC; NCCIH).
Sources
- NCCIH. Rhodiola. Last updated April 2025. https://www.nccih.nih.gov/health/rhodiola
- NCCIH. Ashwagandha. Last updated March 2023. https://www.nccih.nih.gov/health/ashwagandha
- NIH Office of Dietary Supplements. Ashwagandha: Is it helpful for stress, anxiety, or sleep? Health Professional Fact Sheet. Updated May 2, 2025. https://ods.od.nih.gov/factsheets/Ashwagandha-HealthProfessional/
- Memorial Sloan Kettering Cancer Center. About Herbs: Rhodiola. Last updated April 16, 2026. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/rhodiola
- Memorial Sloan Kettering Cancer Center. About Herbs: Ashwagandha. Last updated July 28, 2026. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/ashwagandha
- Drugs.com. Rhodiola rosea (Natural Products, Pro). Last updated July 13, 2026. https://www.drugs.com/npp/rhodiola-rosea.html
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Ashwagandha. [Updated 2024 Dec 3]. Accessed 31 October 2026. https://www.ncbi.nlm.nih.gov/books/NBK548536/
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Herbal and Dietary Supplements. [Updated 2025 Jul 1]. Accessed 31 October 2026. https://www.ncbi.nlm.nih.gov/books/NBK548441/
- European Medicines Agency, HMPC. European Union herbal monograph on Rhodiola rosea L., rhizoma et radix, Revision 1 (EMA/HMPC/24177/2023), 20 March 2024. https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-rhodiola-rosea-l-rhizoma-et-radix-revision-1_en.pdf
- European Medicines Agency, HMPC. Public statement on Withania somnifera (L.) Dunal, radix (EMA/HMPC/681519/2012), 9 July 2013. https://www.ema.europa.eu/en/documents/public-statement/final-public-statement-withania-somnifera-l-dunal-radix-first-version_en.pdf
- Fødevarestyrelsen (Danish Veterinary and Food Administration). Ashwagandha i kosttilskud og drikkevarer. https://foedevarestyrelsen.dk/kost-og-foedevarer/alt-om-mad/kemi-i-maden/mad-med-uoensket-kemi/ashwagandha
- Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract. Medicine (Baltimore). 2019;98(37):e17186. https://pubmed.ncbi.nlm.nih.gov/31517876/
- Lopresti AL, Drummond PD, Smith SJ. A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha in aging, overweight males. Am J Mens Health. 2019;13(2):1557988319835985. https://pubmed.ncbi.nlm.nih.gov/30854916/
- Salve J, Pate S, Debnath K, Langade D. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults. Cureus. 2019;11(12):e6466. https://pubmed.ncbi.nlm.nih.gov/32021735/
- Akhgarjand C, et al. Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022;36(11):4115-4124. https://pubmed.ncbi.nlm.nih.gov/36017529/
- Olsson EM, von Schéele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009;75(2):105-112. https://pubmed.ncbi.nlm.nih.gov/19016404/
- Ishaque S, Shamseer L, Bukutu C, Vohra S. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complement Altern Med. 2012;12:70. https://pubmed.ncbi.nlm.nih.gov/22643043/
- Punja S, Shamseer L, Olson K, Vohra S. Rhodiola rosea for mental and physical fatigue in nursing students: a randomized controlled trial. PLoS One. 2014;9(9):e108416. https://pubmed.ncbi.nlm.nih.gov/25268730/
- Mao JJ, Xie SX, Zee J, et al. Rhodiola rosea versus sertraline for major depressive disorder: a randomized placebo-controlled trial. Phytomedicine. 2015;22(3):394-399. https://pubmed.ncbi.nlm.nih.gov/25837277/ (full text: https://pmc.ncbi.nlm.nih.gov/articles/PMC4385215/)
- Łuszczak J, Kocki J. Clinical evidence for the adaptogenic effects of Withania somnifera and Rhodiola rosea — a systematic review with molecular interpretation of psychometric outcomes. Ann Agric Environ Med. 2026;33(1):3-11. https://pubmed.ncbi.nlm.nih.gov/41906501/
- Booker A, Zhai L, Gkouva C, Li S, Heinrich M. From Traditional Resource to Global Commodities: A Comparison of Rhodiola Species Using NMR Spectroscopy—Metabolomics and HPTLC. Front Pharmacol. 2016;7:254. https://pmc.ncbi.nlm.nih.gov/articles/PMC5002433/
- CITES. Appendices I, II and III, valid from 5 March 2026. https://cites.org/eng/app/appendices.php
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. SLIMQUICK. [Updated 2021 Sep 3]. Accessed 31 October 2026. https://www.ncbi.nlm.nih.gov/books/NBK548570/
- Thu OK, Spigset O, Nilsen OG, Hellum B. Effect of commercial Rhodiola rosea on CYP enzyme activity in humans. Eur J Clin Pharmacol. 2016;72(3):295-300. https://pubmed.ncbi.nlm.nih.gov/26613955/
- Sarris J, Ravindran A, Yatham LN, et al. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. World J Biol Psychiatry. 2022;23(6):424-455. https://pubmed.ncbi.nlm.nih.gov/35311615/
- Lam RW, Kennedy SH, Adams C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Can J Psychiatry. 2024;69(9):641-687. https://pubmed.ncbi.nlm.nih.gov/38711351/ (corrigendum: Can J Psychiatry. 2025;70(8):652)
This page is for general information only and isn't medical advice. Talk with a doctor or pharmacist before taking any herb or supplement. Full disclaimer
